NASDAQ: MARPSMarine Petroleum Trust Stock
$3.90+0.00 (+0%)
Updated Apr 21, 2025
MARPS Price
$3.90
Fair Value Price
N/A
Market Cap
$7.79M
52 Week Low
$3.76
52 Week High
$5.20
P/E
12.57x
P/B
8.81x
P/S
8.4x
PEG
3.92x
Dividend Yield
8.49%
Revenue
$945.50k
Earnings
$600.56k
Gross Margin
100%
Operating Margin
63.52%
Profit Margin
63.5%
Debt to Equity
0
Operating Cash Flow
N/A
Beta
0.41
Next Earnings
May 12, 2025
Ex-Dividend
N/A
Next Dividend
N/A
MARPS Overview
Marine Petroleum Trust, together with its subsidiary, Marine Petroleum Corporation, operates as a royalty trust in the United States. As of June 30, 2021, the company had an overriding royalty interest in 55 oil and natural gas leases covering approximately 199,868 gross acres located in the Central and Western areas of the Gulf of Mexico off the coasts of Louisiana and Texas. Marine Petroleum Trust was incorporated in 1956 and is based in Dallas, Texas.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine MARPS's potential to beat the market
- MARPS doesn't meet the minimum data requirements for our proprietary Zen Ratings model. Learn more about Zen Ratings.
Zen Rating Component Grades
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Oil & Gas Midstream
Industry Rating
D
MARPS
RankedUnranked of 42
RankedUnranked of 42
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $26.20 | A | |
| $49.22 | B | |
| $3.31 | B |
Be the first to know about important MARPS news, forecast changes, insider trades & much more!
MARPS News
Overview
Due Diligence Score
–
Industry Average (32)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how MARPS scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
MARPS ($3.90) is trading above its intrinsic value of $2.03, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
MARPS is good value based on its earnings relative to its share price (12.57x), compared to the US market average (27.14x)
P/E vs Market Valuation
MARPS is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more MARPS due diligence checks available for Premium users.
Valuation
MARPS price to earnings (PE)
For valuing profitable companies with steady earnings
Company
12.57x
Industry
19.46x
Market
27.14x
MARPS is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
MARPS is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
MARPS price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
8.81x
Industry
2.77x
MARPS is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
MARPS price to earnings growth (PEG)
For valuing profitable companies with growth potential
MARPS is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
MARPS's financial health
Profit margin
Revenue
$165.9k
Net Income
$81.1k
Profit Margin
48.9%
MARPS's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$884.3k
Liabilities
$0.0
Debt to equity
0
MARPS's short-term assets ($884.29k) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
MARPS's short-term assets ($884.29k) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
MARPS's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
MARPS's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
N/A
Investing
N/A
Financing
N/A
MARPS vs Oil & Gas Midstream Stocks
Marine Petroleum Trust Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.